PRF Technologies readies Phase 2 trial of LayerBio’s OcuRing-K cataract surgery implant
PRFX•Phase 2 trial preparations underway
PRF Technologies flagged preparations to start a planned Phase 2 trial of LayerBio’s OcuRing-K for use during cataract surgery.
No clinical results were presented; the update focused on readiness work ahead of trial initiation.
The program is positioned as a potential alternative to eye drops, aiming to simplify post-surgery care and improve patient comfort.
